US Penny Stocks Under $90M Market Cap To Watch

As the U.S. stock market takes a breather after a significant post-election rally, investors are assessing their portfolios amid heightened optimism and fluctuating indices. In this context, penny stocks—often representing smaller or newer companies—remain an intriguing investment area despite their vintage name. These stocks can offer growth opportunities at lower price points when backed by solid financials, presenting potential for impressive returns without the typical risks associated with this segment of the market.

Top 10 Penny Stocks In The United States

Name	Share Price	Market Cap	Financial Health Rating
BAB (OTCPK:BABB)	$0.78	$5.56M	★★★★★★
RLX Technology (NYSE:RLX)	$1.60	$2.07B	★★★★★★
QuantaSing Group (NasdaqGM:QSG)	$3.08	$170.72M	★★★★★★
AsiaFIN Holdings (OTCPK:ASFH)	$0.97	$79.11M	★★★★★★
Flexible Solutions International (NYSEAM:FSI)	$4.37	$51.05M	★★★★★★
Data Storage (NasdaqCM:DTST)	$4.84	$33.86M	★★★★★★
PHX Minerals (NYSE:PHX)	$3.35	$128.93M	★★★★★☆
So-Young International (NasdaqGM:SY)	$1.25	$88.26M	★★★★☆☆
Better Choice (NYSEAM:BTTR)	$2.15	$3.78M	★★★★★★
ZTEST Electronics (OTCPK:ZTST.F)	$0.255	$9.81M	★★★★★★

Click here to see the full list of 738 stocks from our US Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Aadi Bioscience (NasdaqCM:AADI)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Aadi Bioscience, Inc. is a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, with a market cap of $52.38 million.

Operations: Aadi Bioscience, Inc. has not reported any revenue segments.

Market Cap: $52.38M

Aadi Bioscience, Inc., with a market cap of US$52.38 million, is navigating significant strategic shifts amid its current unprofitable status. The company reported third-quarter revenue of US$7.21 million, an increase from the previous year, yet it continues to incur net losses. Recent operational changes include halting a key clinical trial and reducing its workforce by 32% to extend its cash runway into at least the second half of 2026. Despite these challenges, Aadi remains debt-free with short-term assets exceeding both short and long-term liabilities, providing some financial stability in this volatile sector.

• Jump into the full analysis health report here for a deeper understanding of Aadi Bioscience.
• Examine Aadi Bioscience's earnings growth report to understand how analysts expect it to perform.

PodcastOne (NasdaqCM:PODC)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: PodcastOne, Inc. operates as a podcast platform and publisher with a market cap of $34.82 million.

Operations: PodcastOne, Inc. has not reported any revenue segments.

Market Cap: $34.82M

PodcastOne, Inc., with a market cap of US$34.82 million, has shown promising revenue growth despite its unprofitable status. Recent earnings for the second quarter ended September 30, 2024, reported sales of US$12.15 million, up from US$10.52 million a year ago, while reducing net loss significantly to US$1.67 million from US$10.87 million previously. The company forecasts fiscal 2025 revenues to grow by at least 17%, reaching at least US$51 million. Despite shareholder dilution and high volatility in share price, PodcastOne remains debt-free with sufficient cash runway for over three years if current positive free cash flow persists.

• Take a closer look at PodcastOne's potential here in our financial health report.
• Review our growth performance report to gain insights into PodcastOne's future.

Stabilis Solutions (NasdaqCM:SLNG)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Stabilis Solutions, Inc. is an energy transition company that offers clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) across various end markets in North America, with a market cap of $82.05 million.

Operations: There are no specific revenue segments reported for this energy transition company focused on clean energy solutions involving liquefied natural gas in North America.

Market Cap: $82.05M

Stabilis Solutions, Inc., with a market cap of US$82.05 million, has transitioned to profitability, reporting third-quarter 2024 sales of US$17.63 million and net income of US$0.997 million compared to a loss last year. The company shows financial stability with short-term assets exceeding liabilities and debt well-covered by operating cash flow. Its management team is experienced, and the board has seasoned tenure. Despite low return on equity at 6%, Stabilis' shares trade significantly below estimated fair value without meaningful shareholder dilution over the past year, indicating potential growth opportunities in the clean energy sector using LNG solutions across North America.

• Click here to discover the nuances of Stabilis Solutions with our detailed analytical financial health report.
• Gain insights into Stabilis Solutions' historical outcomes by reviewing our past performance report.

Summing It All Up

• Click here to access our complete index of 738 US Penny Stocks.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Ready For A Different Approach?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com